
Keywords: 1-اتیل-3- (3-dimethylaminopropyl) carbodiimide; magnetic nanoparticles; drug delivery; chemotherapy; MRI-contrast agents; breast adenocarcinoma; iron oxide; BSA; bovine serum albumin; MNP; PEGylated albumin coated magnetic nanoparticles; VEGF; vascular endothelial growth factor; Dox; doxorubicin; MRI;